Crossmark

Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s12185-021-03234-3

Published Online: 2022-01-23

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamada, Yuta

Konishi, Tatsuya

Nagata, Akihito

Toya, Takashi

Najima, Yuho

Kobayashi, Takeshi

Ohashi, Kazuteru

Doki, Noriko https://orcid.org/0000-0002-8661-3179
License Information

Text and Data Mining valid from 2022-01-23

Version of Record valid from 2022-01-23
More Information

Article History

Received: 23 August 2021

Revised: 5 October 2021

Accepted: 5 October 2021

First Online: 23 January 2022

Declarations

:

: The authors declare no conflict of interest.

: Our institutional committee on research ethics approved the study, which was performed in compliance with the Declaration of Helsinki.

Document is current

Any future updates will be listed below